Actionable news
0
All posts from Actionable news
Actionable news in GWPH: GW Pharmaceuticals Plc,

Cara Therapeutics to Present at 2nd Human Abuse Liability & Abuse-Deterrent Formulations Conference

  • Chief Medical Officer Dr. Joseph Stauffer to discuss potential for kappa opioids

SHELTON, Conn., Oct. 26, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that its Chief Medical Officer, Joseph Stauffer, D.O., M.B.A., will lead a track on "Technical Breakthroughs in Abuse Deterrence" at the 2nd Human Abuse Liability & Abuse-Deterrent Formulations conference on Tuesday, November 3, 2015, at the Hyatt Regency Bethesda in Bethesda, Maryland.

In addition, Dr. Stauffer will deliver an oral presentation titled "Analyze the Scientific and Market Potential for Kappa Opioids" on Tuesday, November 3 from 11:00 to 11:45 a.m. ET, during which he will discuss developments in kappa opioid receptor...


More